MARC Record from marc_columbia

LEADER: 06213cam a2200805 i 4500
001 13598777
005 20220402224548.0
006 m o d
007 cr |||||||||||
008 150619s2016 enk ob 001 0 eng
010 $a 2015024602
035 $a(OCoLC)ocn911255369
035 $a(NNC)13598777
040 $aDLC$beng$erda$epn$cDLC$dOCLCF$dN$T$dYDXCP$dEBLCP$dDG1$dCDX$dCOO$dDEBBG$dDG1$dCNCGM$dLIP$dCHVBK$dMERUC$dOCLCQ$dKNOVL$dUAB$dSTF$dAU@$dCEF$dERL$dOCLCQ$dLVT$dYDX$dU3W$dOCLCQ$dOCLCO
019 $a951601800$a992904507
020 $a9781523114719$q(electronic bk.)
020 $a1523114711$q(electronic bk.)
020 $z9781118696286
020 $z111869628X
020 $z9781118696293
020 $z1118696298
020 $z9781118697856
020 $z1118697855
020 $z111860525X
020 $z9781118605257
035 $a(OCoLC)911255369$z(OCoLC)951601800$z(OCoLC)992904507
042 $apcc
050 00 $aTP248.65.E59
072 7 $aSCI$x013060$2bisacsh
072 7 $aTEC$x009010$2bisacsh
082 00 $a660.6/34$223
049 $aZCUA
245 00 $aPractical methods for biocatalysis and biotransformations 3 /$cedited by John Whittall, Manchester Interdisciplinary Biocentre (MIB), the University of Manchester, UK, Peter Sutton, GlaxoSmithKline Research and Development Limited, UK, Wolfgang Kroutil, University of Graz, Austria.
250 $a3.
264 1 $aChichester, West Sussex :$bJohn Wiley & Sons, Ltd.,$c2016.
300 $a1 online resource
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
504 $aIncludes bibliographical references and index.
588 0 $aPrint version record and CIP data provided by publisher.
505 0 $aPractical Methods for Biocatalysis and Biotransformations 3; Contents; List of Contributors; Abbreviations; Chapter 1: Considerations for the Application of Process Technologies in Laboratory- and Pilot-Scale Biocatalysis for Chemical Synthesis; 1.1 Introduction; 1.2 Process Intensification and Proposed Scale-Up Concept; 1.3 Enabling Technologies; 1.3.1 Biocatalyst Immobilization; 1.3.1.1 General Considerations for Implementation; 1.3.1.2 Carrier-Bound Supported Enzymes; 1.3.1.2.1 Adsorption; Considerations for Implementation; 1.3.1.2.2 Covalent Binding; Considerations for Implementation.
505 8 $a1.3.1.2.3 Ionic BindingConsiderations for Implementation; 1.3.1.3 Carrier-Free Immobilization; 1.3.1.3.1 Cross-Linked Enzyme Aggregates (CLEAsTM); Considerations for Implementation; 1.3.2 Reactor Options; 1.3.2.1 Ideal Reactors; 1.3.2.2 Modes of Operation; 1.3.2.3 Well-Mixed Reactor Hydrodynamics; 1.3.2.3.1 Stirred Tanks; Considerations for Implementation; 1.3.2.3.2 Batch Stirred-Tank Reactors (BSTRs); Considerations for Implementation; 1.3.2.3.3 Continuous Stirred-Tank Reactors (CSTRs); Considerations for Implementation; 1.3.2.3.4 Alternative Well-Mixed Reactors.
505 8 $aContinuous Fluidized-Bed Reactors (CFBRs)Considerations for Implementation; Continuous Packed-Bed Reactors (CPBRs); Considerations for Implementation; Continuous Expanded-Bed Reactors (CEBRs); Considerations for Implementation; 1.3.2.3.5 Membrane Bioreactors (MBRs); Considerations for Implementation; 1.4 Enhancing Technologies; 1.4.1 In Situ Product Removal (ISPR); 1.4.1.1 Considerations for Implementation; 1.4.1.2 ISPR by Adsorption on Resins; 1.4.1.2.1 Considerations for Implementation; 1.4.1.3 ISPR Using Expanded-Bed Adsorption (EBA); 1.4.1.3.1 Considerations for Implementation.
505 8 $a1.4.1.4 ISPR by Crystallization1.4.1.4.1 Considerations for Implementation; 1.4.2 Substrate Feeding Strategies; 1.4.2.1 Fed-Batch Operation; 1.4.2.1.1 Considerations for Implementation; 1.4.3 Non-Conventional Media; 1.4.3.1 Single Non-Conventional Liquid Phase Systems; 1.4.3.1.1 Considerations for Implementation; 1.4.3.2 Aqueous-Organic Two-Liquid Phase Systems; 1.4.3.2.1 Considerations for Implementation; 1.4.3.3 Aqueous-Ionic Liquid Two-Liquid Phase Systems; 1.4.3.3.1 Considerations for Implementation; 1.4.4 Oxygen Supply Strategies; 1.4.4.1 Surface Aeration.
505 8 $a1.4.4.1.1 Considerations for Implementation1.4.4.2 Sparged Aeration; 1.4.4.2.1 Considerations for Implementation; 1.4.4.3 Bubble-Column Reactors; 1.4.4.3.1 Considerations for Implementation; 1.5 Conclusion; References; Chapter 2: Cytochrome P450 (CYP) Progress in Biocatalysis for Synthetic Organic Chemistry; 2.1 Introduction; 2.2 CYP Development; 2.3 Recent Developments; 2.4 Conclusion; References; Chapter 3: Use of Hydrolases and Related Enzymes for Synthesis; 3.1 Continuous-Flow Reactor-Based Enzymatic Synthesis of Phosphorylated Compounds on a Large Scale; 3.1.1 Materials and Equipment.
650 0 $aEnzymes$xBiotechnology.
650 0 $aBiocatalysis.
650 0 $aBiotransformation (Metabolism)
650 0 $aOrganic compounds$xSynthesis.
650 2 $aBiocatalysis
650 2 $aBiotransformation
650 6 $aEnzymes$xBiotechnologie.
650 6 $aBiocatalyse.
650 6 $aBiotransformation (Métabolisme)
650 6 $aComposés organiques$xSynthèse.
650 7 $aSCIENCE$xChemistry$xIndustrial & Technical.$2bisacsh
650 7 $aTECHNOLOGY & ENGINEERING$xChemical & Biochemical.$2bisacsh
650 7 $aBiocatalysis.$2fast$0(OCoLC)fst01896571
650 7 $aBiotransformation (Metabolism)$2fast$0(OCoLC)fst00832858
650 7 $aEnzymes$xBiotechnology.$2fast$0(OCoLC)fst00913608
650 7 $aOrganic compounds$xSynthesis.$2fast$0(OCoLC)fst01047668
655 4 $aElectronic books.
700 1 $aWhittall, John,$eeditor.
700 1 $aSutton, Peter$q(Peter W.),$eeditor.
700 1 $aKroutil, Wolfgang,$d1972-$eeditor.
776 08 $iPrint version:$tPractical methods for biocatalysis and biotransformations.$b3.$dChichester, West Sussex : John Wiley & Sons, Ltd., 2016$z9781118605257$w(DLC) 2015024267
856 40 $uhttp://www.columbia.edu/cgi-bin/cul/resolve?clio13598777.001$zACADEMIC - Biochemistry, Biology & Biotechnology
856 40 $uhttp://www.columbia.edu/cgi-bin/cul/resolve?clio13598777.002$zACADEMIC - Chemistry & Chemical Engineering
852 8 $blweb$hEBOOKS